Cereve is a division of Medtronic (NYSE: MDT) focused on sleep disorder therapies and medical devices. Headquartered in Minneapolis, Minnesota, Cereve develops continuous positive airway pressure (CPAP) devices and sleep monitoring technologies for the treatment of sleep apnea and other sleep disorders.
While Cereve's primary focus is on obstructive sleep apnea (OSA), their expertise in sleep medicine positions them as a potential player in addressing sleep disorders associated with neurodegenerative diseases, including Parkinson's disease-related sleep dysfunction.
| Product | Indication | Status |
|---|---|---|
| AirSense 11 CPAP | Sleep apnea | Marketed |
| AirCurve Bi-level | Complex sleep apnea | Marketed |
| Cereve Sleep Lab | Diagnostic equipment | Marketed |
Cereve's devices incorporate advanced monitoring features that could be adapted for neurodegenerative disease applications:
Sleep disorders are among the most common non-motor symptoms in PD, affecting up to 90% of patients:
While Cereve's current products are not specifically indicated for RBD, their technology could be adapted for:
Cereve (Medtronic) is one of the leading players in the sleep therapy market:
| Company | Products | Focus |
|---|---|---|
| ResMed | CPAP, ASV | Sleep apnea, respiratory care |
| Philips Respironics | CPAP, BiPAP | Sleep and respiratory (recalls impacting) |
| Fisher & Paykel | CPAP, humidification | Sleep therapy |
| ImThera (Samsung) | Tongue stimulation | Sleep apnea |
Medtronic invests significantly in sleep therapy R&D:
Cereve's potential role in neurodegenerative disease-related sleep disorders includes: